Obesity drugmaker Novo Nordisk misses Q2 profit forecast
By Maggie FickLONDON (Reuters) -Novo Nordisk on Wednesday posted second-quarter operating profit below expectations, raised its 2024 sales forecast but…
Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.SEBASTIEN BOZON | AFP | Getty ImagesNovo Nordisk and…
Catalent stock downgraded post Novo Nordisk acquisition deal By Investing.com
© Reuters. On Tuesday, Wall Street analysts adjusted their ratings for Catalent, Inc. (NYSE:) following the announcement of its acquisition…
Novo Nordisk hits $500bn market value as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the…
Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic
Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular…
Financials lift European shares higher; Novo Nordisk hits record high By Reuters
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 24,…
Novo Nordisk sees double-digit FY growth; boosts Wegovy supplies to U.S
COPENHAGEN/LONDON (Reuters) - Novo Nordisk on Wednesday forecast another year of double-digit record sales and operating profit growth as it…
Lilly, Novo Nordisk top pharma performers in August
marekuliasz/iStock via Getty Images Sales of diabetes and weight loss drugs are booming, propelling Eli Lilly (NYSE:LLY) and Novo Nordisk…
Aramco, Siemens Energy, Novo Nordisk Top European Earnings to Watch Next Week
Breadcrumb Trail Links PMN Business As a dense but brief European earnings season draws to a close, a handful of…
Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market By Reuters
© Reuters. FILE PHOTO: The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a…